# Amedrix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amedrix

- Industry: Medical Devices & Equipment
- Headquarters: Esslingen, Germany
- Website: www.amedrix.de
- Total disclosed funding: $1.1M
- Latest round: Seed (Nov 20, 2009)
- Investors on record: 1

## About

Amedrix GmbH is a German company specializing in the development and manufacturing of innovative orthobiological medical products that focus on regenerative therapies for joint cartilage injuries.Founded in 2009, Amedrix GmbH is located in Esslingen, Germany. The company focuses on developing advanced medical solutions for joint cartilage injuries. It has secured funding through two deals, with the latest being a Seed round in July 2013, raising EUR 0.700 mn from High-Tech Gründerfonds. The total amount raised by the company stands at EUR 0.700 mn, with a current valuation of EUR 5.490 mn.Amedrix GmbH specializes in the development and manufacturing of innovative orthobiological medical products, particularly focusing on regenerative therapies for joint cartilage injuries. Their flagship product, ChondroFiller® liquid, effectively treats cartilage defects up to 3 cm², utilizing advanced techniques for administration in difficult joint areas. The primary clientele includes healthcare providers across Europe, notably in Germany, Austria, and Switzerland, responding to the rising demand for joint care solutions.In the most recent fiscal year (2016), Amedrix GmbH reported revenue of EUR 775,141.30. The revenue model is structured around direct sales to healthcare institutions, primarily targeting B2B transactions. Clients order ChondroFiller® liquid and related products through established distribution channels, ensuring access to regenerative therapies.Amedrix GmbH is strategizing future growth through the development of new products aimed at enhancing cartilage regeneration. Although specific product launch timelines are not provided, the company aims to expand into new European markets to enhance its outreach. The recent Seed funding round, raised in July 2013, will aid in supporting these initiatives, particularly in bolstering research and development efforts.

## Funding rounds

- Seed, Nov 20, 2009, $1.1M — High-Tech Gruenderfonds

## Investors

- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed